The Role of Adverse Event Reporting in the FDA Response to a Multistate Outbreak of Liver Disease Associated with a Dietary Supplement.

@article{Klontz2015TheRO,
  title={The Role of Adverse Event Reporting in the FDA Response to a Multistate Outbreak of Liver Disease Associated with a Dietary Supplement.},
  author={Karl C. Klontz and Heidi J DeBeck and P Leblanc and Kathryn M Mogen and Beverly J. Wolpert and Jonathan L. Sabo and Monique Salter and Sharon L Seelman and Susan E Lance and Caitlin Monahan and David S Steigman and Kathleen Gensheimer},
  journal={Public health reports},
  year={2015},
  volume={130 5},
  pages={526-32}
}
OBJECTIVE Liver disease is a potential complication from using dietary supplements. This study investigated an outbreak of non-viral liver disease associated with the use of OxyELITE Pro(TM), a dietary supplement used for weight loss and/or muscle building. METHODS Illness details were ascertained from MedWatch reports submitted to the U.S. Food and Drug Administration (FDA) describing consumers who ingested OxyELITE Pro alone or in combination with other dietary supplements. FDA's Forensic… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Adverse Effects of Nutraceuticals and Dietary Supplements.

Annual review of pharmacology and toxicology • 2018
View 20 Excerpts
Highly Influenced

RUCAM in Drug and Herb Induced Liver Injury: The Update

International journal of molecular sciences • 2015
View 7 Excerpts
Highly Influenced

Suspected Liver Injury and the Dilemma of Causality

Digestive Diseases and Sciences • 2016
View 3 Excerpts

Similar Papers

Loading similar papers…